ECP 2019 Final Programme

Sunday, 8 Sept 80 ECP 2019 · Nice Poster Sessions a Sunday PS-01 e Sunday, 8 September 2019 PS-01 Poster Session Breast Pathology Chairs: Snježana Tomić, Croatia Cecily Quinn, Ireland Päivi Heikkilä, Finland 001 Breast implant-associated squamous cell carcinoma Luis Alfaro, Spain M. J. Roca, A. Jimènez, C. Vázquez 002 Reliability of HER2 immunohistochem istry in invasive breast carcinomas with micropapillary features Nazli Eylem Alkanat, Turkey L. Atakishieva, Z. Kadylbek, A. Uner, K. Kosemehmetoglu 003 ASCO / CAP testing guidelines in breast cancer: impact of the updated recommen- dations Xavier Ara-Mancebo, Spain C. Alborch, E. Fuentes-Camps, S. Ramón y Cajal, V. Peg-Camara 004 TMA or whole slides to assess TILs in early-stage triple-negative breast cancer Anna Artemyeva, Russia D. Chuglova, V. Kushnarev, P. Krivorotko, A. Kudaybergenova 005 Stathmin expression is associated with immune cell responses and vascular proliferation in breast cancer Cecilie Askeland, Norway E. Wik, I. Stefansson, K. Krüger, K. Collett, G. Knutsvik, J. Arnes, T. Aas, L. A. Akslen 006 Prognostic value of stromal CD10 expression in invasive breast carcinoma Rahma Ayadi, Tunisia D. Bacha, O. Belkacem, R. Yaiche, A. Ben Amor, S. Gharbi, S. Ben Slama, A. Lahmar, S. Bouraoui 008 Agreement between immunohistochemi- cally defined intrinsic subtype estimation and Prosigna breast cancer prognostic gene signature assay in a clinical cohort at the Medical University of Vienna Zsuzsanna Bago-Horvath, Austria K. Tendl, L. Monschein, R. Exner, F. Fitzal, E. Bergen, M. Seifert, C. Singer, M. Rudas, L. Müllauer 009 Retrospective analysis of 2200 HER2 cases evaluated according to the 2013 ASCO / CAP guidelines and its correlation with the updated 2018 guideline and its impact in HER2 status Rocio Irene Bermudez Cameo, Spain H. P. Almanzar Comas, B. Eizaguirre Zarza, S. Bakali Badesa, J. I. Franco, M. J. Viso Soriano, A. Sobrino Prados, A. Arellano Alvarez, N. Estrada Mallarino, C. Del Agua, E. Gimeno Esteras, V. Sanz Salvador, V. Malo Nieves 010 Heterogeneity of cancer-associated fibroblasts in invasive carcinoma of no special type (IC NST) Tatiana Bezuglova, Russia L. V. Kaktursky, M. Mnikhovich, A. Asaturova, V. Kometova, I. V. Vasin, S. V. Snegur, D. S. Kusch, N. G. Malyugin 011 Metastastic renal cell carcinoma of sarcomatoid type simulating generalised breast cancer; a case report and our experiences between 2000 and 2018 Ida Björnheden, Sweden 012 Breast metastases from non-mammary neoplasms. A study of 20 cases Jan Bosch Schips, Spain C. Fabregat, A. Stradella, L. Pèrez-Tapia, A. Petit, M. R. Taco, E. Guerra, I. Català, R. Campos de Pablo, G. Ippoliti, X. Matias-Guiu, M. T. Soler-Monsó 014 The relationship between tumour-infiltrating lymphocytes, vascular invasion and stromal elastosis in breast cancer Ying Chen, Norway T. A. Klingen, H. Aas, E. Wik, L. A. Akslen